The global Pain Therapeutic Injectables Market holds a valuation of USD 19.3 Billion in 2023, and it is further projected to expand at a CAGR of 4.5% over the forecasted years. According to a recent study by Future Market Insights, opioids are leading the market with a share of about 53.4% in the year 2022, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2023 | USD 19.3 Billion |
| Market Value 2033 | USD 30.9 Billion |
| CAGR 2023 to 2033 | 4.5% |
| Market Share of Top 5 Countries | 59.1% |
| Key Market Players | AbbVie Inc. (Allergan plc), Bristol Myers Squibb Co., Sanofi S.A., Boehringer Ingelheim International GmbH, Pfizer Inc., Zydus Lifesciences Ltd. (Cadila Pharmaceuticals), GSK plc., Abbott Laboratories, Inc., Novartis AG, Johnson & Johnson (Janssen Pharmaceuticals, Inc.), Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Procter & Gamble, AstraZeneca, Cardinal Health, Perrigo Company Plc., Bausch Health Companies Inc., Viatris, Amneal Pharmaceuticals, and Purdue Pharmaceuticals L.P. |
Therapeutic injections for treating pain can aid in reducing swelling and discomfort. Depending on the location, muscle injury, skeletal or neurological structures, and overall symptoms, there are choices for injectable treatment for almost any sort of pain a patient is experiencing.
These injections can be administered intravenously, subcutaneously, or through an epidural catheter. These injectables are frequently used to treat acute pain which occurs because of injuries, post-operative pain, or chronic pain due to any kind of illness.
The global market holds around 28.5% share of the overall global painkillers market with a value of around USD 67.7 Billion, in 2022.
The increasing prevalence of chronic pain conditions, such as arthritis, cancer pain, and lower back pain, is one of the primary drivers of the pain therapeutic injectables market. These conditions require long-term pain management, which often includes the use of injectable pain medications. Due to the rise in chronic diseases, the market for pain therapeutic injectables has exhibited a consistent increase.
Apart from this, the market is anticipated to expand in the coming years because of the rising number of surgeries performed worldwide. This eventually demands post-operative pain management. Moreover, technological developments have led to improvements in drug delivery systems which ensures more accurate and effective administration of injectable drugs.
As the importance of pain management becomes more widely recognized, patients are seeking out effective pain relief options that can improve their quality of life. Pain therapeutic injectables are one such option that can provide rapid and effective relief from pain.
Owing to the above-mentioned factors, the global market is expected to grow at a prominent pace, and reach a valuation of around USD 30.9 billion in the year 2033.
There are numerous potentials for innovation and expansion in the market for companies dealing in pain therapeutic injectables. The market is being driven by the rising demand for minimally invasive procedures worldwide.
Minimally invasive procedures, such as injections, are becoming increasingly popular among patients due to their ability to reduce pain and discomfort while minimizing the risk of complications. This is driving the demand for pain therapeutic injectables, which can provide effective pain relief with minimal invasiveness.
The development of this market is anticipated to be aided by a number of new technologies and therapies. Due to their efficiency and patient convenience, injectable pain treatments are anticipated to see increased use.
As the global population ages, the prevalence of chronic pain conditions is expected to increase, which will drive demand for pain therapeutic injectables. The geriatric population is particularly susceptible to chronic pain, making them a key demographic for the pain therapeutic injectables market.
The market is constrained by a number of factors, including expensive injectable drug costs, adverse effects from prolonged use of opioids, and the possibility of drug abuse and addiction. Pain therapeutic injectables can be expensive, which can limit access for some patients. This is particularly true for those who do not have adequate health insurance coverage or who are underinsured.
The regulatory environment is also posing difficulties for the market, particularly when it comes to confirming the efficacy and safety of new injectable treatments before they can be released. The development and approval of new pain medications can be a lengthy and expensive process due to the strict regulatory requirements in many countries. This can limit the number of new products entering the market and slow down innovation.
The USA dominates the global region with a total market share of around 39.1% in 2022 and is expected to continue to experience the same growth throughout the forecast period.
The market for pain therapeutic injectables in the USA is expanding due to a number of factors. One of the contributing aspects is the increasing prevalence of chronic pain. Chronic pain is a major healthcare issue in the United States, affecting millions of people each year. This has led to a growing demand for pain management therapies, including pain therapeutic injectables.
Other than this, an increase in awareness and education regarding the advantages of injectable painkillers such as their quicker onset of action and more accurate dosing, among medical professionals and patients, is driving the market in this region. In USA, the growth of the market is also fueled by the creation of novel and sophisticated injectable medications as well as the increased availability of enhanced delivery methods. These advancements are driving growth in the market by providing better treatment options for patients.
Japan contributed around USD 1.1 Billion revenue to the global pain therapeutic injectables market in 2022. The prevalence of chronic pain conditions is increasing in Japan, including osteoarthritis, cancer pain, and lower back pain.
This has led to a growing demand for pain therapeutic injectables. Additionally, as older people are more likely to have chronic pain, Japan's aging population is fueling the demand for pain management therapies, including pain therapeutic injectables.
The development of this market has also been aided by technological developments and the accessibility of new painkillers and treatments in Japan. The demand for pain treatment injectables in Japan has also been significantly influenced by patients' and healthcare professionals' growing knowledge regarding the importance of effective pain management.
Germany held a market share of 25.6% in the Western Europe pain therapeutic injectables market in 2022.
The market is expanding in Germany due to the growing popularity of minimally invasive procedures for pain management, which frequently involves the use of injectable medications.
Other than this, the demand for pain treatment injectables in the nation is also being fueled by the growing importance of at-home healthcare and self-administration of injectables. Overall, it is anticipated that these factors will continue to fuel the market for pain therapeutic injectables in Germany in the coming years.
Opioids by drug class segment held 53.4% share in the global market in 2022. Opioids are still frequently used to control pain, especially in situations where there is significant acute pain or chronic pain that does not respond to other forms of treatment. In recent years, although there has been a shift towards the use of non-opioid options for pain management, opioids still have a place in some circumstances.
Overall, opioids play a substantial role in the market of therapeutic injectables for treating pain, but their usage needs to be carefully regulated and balanced with other therapies.
Prescription drugs by product segment contributed around USD 11.3 Billion in the global market in 2022. Since they are frequently used to manage pain in individuals who require more intense therapy, prescription medications play a key role in the market of therapeutic injectables for treating pain.
The market for pain therapeutic injectables also has a prescription medicine sector that is significant because it offers healthcare professionals a variety of treatment alternatives to fulfill the various demands of their patients.
Surgical pain by indication segment held more than one-third revenue share in the global market in 2022. Injectable painkillers are in high demand because of the increasing prevalence of surgical pain conditions.
As a result of tissue damage and inflammation, patients who have undergone surgery, are most likely to experience pain so, pain treatment is a crucial component of post-operative care. Since pain therapeutic injectables can offer more immediate and intense pain relief than oral drugs, these are often utilized to alleviate the discomfort due to the pain.
Retail pharmacies is the leading segment with over 27.0% revenue share in 2022 globally. When it comes to distribution channel, retail pharmacies are considered a place which is quite accessible to patients in order to buy these kinds of injectable drugs. Therefore, retail pharmacies play a significant role in this market. Retail pharmacies typically stock a wide range of medications, including prescription drugs, over-the-counter medications, and other healthcare products. This makes it easy for patients to find the medications they need without having to visit multiple locations.
Key differentiating tactics used by producers of pain therapeutic injectables include an increase in product releases and regulatory body approval, growth into other regions, and marketing approvals in other locations. The dynamics of the market have changed as a result of increasing awareness.
Similarly, recent developments related to companies manufacturing pain therapeutic injectables have been tracked by the team at Future Market Insights. These are available in the full report.
| Attribute | Details |
|---|---|
| Historical Data Available for | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; Central Asia; Russia & Belarus; Balkan & Baltic Countries; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, France, Spain, Italy, BENELUX, Nordic Countries, United Kingdom, Poland, Hungary, Romania, Czech Republic, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Australia & New Zealand, Japan, China, South Korea, GCC Countries, Kingdom of Saudi Arabia, Türkiye, Northern Africa, South Africa, and Israel |
| Key Market Segments Covered | Drug Class, Product, Indication, Distribution Channel and Region |
| Key Companies Profiled | AbbVie Inc. (Allergan plc); Bristol Myers Squibb Co.; Sanofi S.A.; Boehringer Ingelheim International GmbH; Pfizer Inc.; Zydus Lifesciences Ltd. (Cadila Pharmaceuticals); GSK plc.; Abbott Laboratories, Inc.; Novartis AG; Johnson & Johnson (Janssen Pharmaceuticals, Inc.); Sun Pharmaceutical Industries Ltd.; Teva Pharmaceuticals Ltd.; Mallinckrodt Pharmaceuticals; Endo Pharmaceuticals Inc.; Bayer AG; F. Hoffmann-La Roche Ltd.; Procter & Gamble; AstraZeneca; Cardinal Health; Perrigo Company Plc.; Bausch Health Companies Inc.; Viatris; Amneal Pharmaceuticals; Purdue Pharmaceuticals L.P. |
| Pricing | Available upon Request |
Table 01: Global Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 02: Global Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 03: Global Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 04: Global Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 05: Global Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 06: Global Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 07: Global Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 08: Global Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 09: Global Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
Table 10: Global Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
Table 11: North America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 12: North America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 13: North America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 14: North America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 15: North America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 16: North America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 17: North America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 18: North America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 19: North America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 20: North America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 21: Latin America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 22: Latin America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 23: Latin America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 24: Latin America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 25: Latin America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 26: Latin America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 27: Latin America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 28: Latin America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 29: Latin America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 30: Latin America Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 31: Western Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 32: Western Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 33: Western Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 34: Western Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 35: Western Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 36: Western Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 37: Western Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 38: Western Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 39: Western Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 40: Western Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 41: Eastern Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 42: Eastern Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 43: Eastern Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 44: Eastern Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 45: Eastern Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 46: Eastern Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 47: Eastern Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 48: Eastern Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 49: Eastern Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 50: Eastern Europe Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 51: South Asia & Pacific Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 52: South Asia & Pacific Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 53: South Asia & Pacific Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 54: South Asia & Pacific Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 55: South Asia & Pacific Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 56: South Asia & Pacific Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 57: South Asia & Pacific Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 58: South Asia & Pacific Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 59: South Asia & Pacific Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 60: South Asia & Pacific Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 61: East Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 62: East Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 63: East Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 64: East Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 65: East Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 66: East Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 67: East Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 68: East Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 69: East Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 70: East Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 71: Central Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 72: Central Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 73: Central Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 74: Central Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 75: Central Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 76: Central Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 77: Central Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 78: Central Asia Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 79: Russia & Belarus Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 80: Russia & Belarus Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 81: Russia & Belarus Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 82: Russia & Belarus Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 83: Russia & Belarus Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 84: Russia & Belarus Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 85: Russia & Belarus Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 86: Russia & Belarus Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 87: Balkan & Baltic Countries Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 88: Balkan & Baltic Countries Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 89: Balkan & Baltic Countries Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 90: Balkan & Baltic Countries Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 91: Balkan & Baltic Countries Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 92: Balkan & Baltic Countries Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 93: Balkan & Baltic Countries Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 94: Balkan & Baltic Countries Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 95: Middle East and Africa Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 96: Middle East and Africa Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 97: Middle East and Africa Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 98: Middle East and Africa Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Class
Table 99: Middle East and Africa Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 100: Middle East and Africa Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
Table 101: Middle East and Africa Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 102: Middle East and Africa Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
Table 103: Middle East and Africa Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 104: Middle East and Africa Market Size (US$ Million) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Figure 01: Global Market Share, By Drug Class, 2023 (E)
Figure 02: Global Market Share, By Product, 2023 (E)
Figure 03: Global Market Share, By Indication, 2023 (E)
Figure 04: Global Market Share, By Distribution Channel, 2023 (E)
Figure 05: Global Market Share, By Country, 2023 (E)
Figure 06: No. of Surgeries Performed in 2022, By Key Countries
Figure 07: Global Market - COVID-19 Impact, 2019-2033
Figure 08: Global Market Value Analysis (US$ Million), 2018 to 2022
Figure 09: Global Market Value Forecast (US$ Million), 2023 to 2033
Figure 10: Global Market Absolute Market Absolute $ Opportunity, 2023 to 2033
Figure 11: Global Market Share Analysis (%), By Drug Class, 2023(E) & 2033(F)
Figure 12: Global Market Y-o-Y Analysis (%), By Drug Class, 2023 to 2033
Figure 13: Global Market Attractiveness Analysis By Drug Class, 2023 to 2033
Figure 14: Global Market Share Analysis (%), By Product, 2023(E) & 2033(F)
Figure 15: Global Market Y-o-Y Analysis (%), By Product, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis By Product, 2023 to 2033
Figure 17: Global Market Share Analysis (%), By Indication, 2023(E) & 2033(F)
Figure 18: Global Market Y-o-Y Analysis (%), By Indication, 2023 to 2033
Figure 19: Global Market Attractiveness Analysis By Indication, 2023 to 2033
Figure 20: Global Market Share Analysis (%), By Distribution Channel, 2023(E) & 2033(F)
Figure 21: Global Market Y-o-Y Analysis (%), By Distribution Channel, 2023 to 2033
Figure 22: Global Market Attractiveness Analysis By Distribution Channel, 2023 to 2033
Figure 23: Global Market Share Analysis (%), By Region, 2023(E) & 2033(F)
Figure 24: Global Market Y-o-Y Analysis (%), By Region, 2023 to 2033
Figure 25: Global Market Attractiveness Analysis By Region, 2023 to 2033
Figure 26: North America Market Share, By Drug Class, 2023 (E)
Figure 27: North America Market Share, By Product, 2023 (E)
Figure 28: North America Market Share, By Indication, 2023 (E)
Figure 29: North America Market Share, By Distribution Channel, 2023 (E)
Figure 30: North America Market Share, By Country, 2023 (E)
Figure 31: North America Market Value (US$ Million) Analysis 2018 to 2022
Figure 32: North America Market Value (US$ Million) Analysis 2023 to 2033
Figure 33: North America Market Attractiveness Analysis by Drug Class, 2023 to 2033
Figure 34: North America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 35: North America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 36: North America Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 37: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 38: USAMarket Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 39: USAMarket Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 40: USAMarket Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 41: USAMarket Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 42: Canada Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 43: Canada Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 44: Canada Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 45: Canada Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 46: Latin America Market Share, By Drug Class, 2023 (E)
Figure 47: Latin America Market Share, By Product, 2023 (E)
Figure 48: Latin America Market Share, By Indication, 2023 (E)
Figure 49: Latin America Market Share, By Distribution Channel, 2023 (E)
Figure 50: Latin America Market Share, By Country, 2023 (E)
Figure 51: Latin America Market Value (US$ Million) Analysis 2018 to 2022
Figure 52: Latin America Market Value (US$ Million) Analysis 2023 to 2033
Figure 53: Latin America Market Attractiveness Analysis by Drug Class, 2023 to 2033
Figure 54: Latin America Market Attractiveness Analysis by Product, 2023 to 2033
Figure 55: Latin America Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 56: Latin America Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 57: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 58: Brazil Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 59: Brazil Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 60: Brazil Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 61: Brazil Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 62: Mexico Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 63: Mexico Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 64: Mexico Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 65: Mexico Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 66: Argentina Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 67: Argentina Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 68: Argentina Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 69: Argentina Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 70: Western Europe Market Share, By Drug Class, 2023 (E)
Figure 71: Western Europe Market Share, By Product, 2023 (E)
Figure 72: Western Europe Market Share, By Indication, 2023 (E)
Figure 73: Western Europe Market Share, By Distribution Channel, 2023 (E)
Figure 74: Western Europe Market Share, By Country, 2023 (E)
Figure 75: Western Europe Market Value (US$ Million) Analysis 2018 to 2022
Figure 76: Western Europe Market Value (US$ Million) Analysis 2023 to 2033
Figure 77: Western Europe Market Attractiveness Analysis by Drug Class, 2023 to 2033
Figure 78: Western Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 79: Western Europe Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 80: Western Europe Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 81: Western Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 82: Germany Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 83: Germany Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 84: Germany Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 85: Germany Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 86: France Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 87: France Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 88: France Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 89: France Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 90: Spain Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 91: Spain Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 92: Spain Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 93: Spain Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 94: Italy Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 95: Italy Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 96: Italy Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 97: Italy Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 98: BENELUX Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 99: BENELUX Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 100: BENELUX Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 101: BENELUX Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 102: Nordic Countries Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 103: Nordic Countries Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 104: Nordic Countries Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 105: Nordic Countries Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 106: UNITED KINGDOMMarket Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 107: UNITED KINGDOMMarket Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 108: UNITED KINGDOMMarket Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 109: UNITED KINGDOMMarket Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 110: Eastern Europe Market Share, By Drug Class, 2023 (E)
Figure 111: Eastern Europe Market Share, By Product, 2023 (E)
Figure 112: Eastern Europe Market Share, By Indication, 2023 (E)
Figure 113: Eastern Europe Market Share, By Distribution Channel, 2023 (E)
Figure 114: Eastern Europe Market Share, By Country, 2023 (E)
Figure 115: Eastern Europe Market Value (US$ Million) Analysis 2018 to 2022
Figure 116: Eastern Europe Market Value (US$ Million) Analysis 2023 to 2033
Figure 117: Eastern Europe Market Attractiveness Analysis by Drug Class, 2023 to 2033
Figure 118: Eastern Europe Market Attractiveness Analysis by Product, 2023 to 2033
Figure 119: Eastern Europe Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 120: Eastern Europe Market Attractiveness Analysis by Distribution Channel, 2023 –2033
Figure 121: Eastern Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 122: Poland Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 123: Poland Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 124: Poland Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 125: Poland Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 126: Hungary Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 127: Hungary Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 128: Hungary Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 129: Hungary Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 130: Romania Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 131: Romania Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 132: Romania Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 133: Romania Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 134: Czech Republic Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 135: Czech Republic Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 136: Czech Republic Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 137: Czech Republic Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033(F)
Figure 138: South Asia & Pacific Market Share, By Drug Class, 2023 (E)
Figure 139: South Asia & Pacific Market Share, By Product, 2023 (E)
Figure 140: South Asia & Pacific Market Share, By Indication, 2023 (E)
Figure 141: South Asia & Pacific Market Share, By Distribution Channel, 2023 (E)
Figure 142: South Asia & Pacific Market Share, By Country, 2023 (E)
Figure 143: South Asia & Pacific Market Value (US$ Million) Analysis 2018 to 2022
Figure 144: South Asia & Pacific Market Value (US$ Million) Analysis 2023 to 2033
Figure 145: South Asia & Pacific Market Attractiveness Analysis by Drug Class, 2023 to 2033
Figure 146: South Asia & Pacific Market Attractiveness Analysis by Product, 2023 to 2033
Figure 147: South Asia & Pacific Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 148: South Asia & Pacific Market Attractiveness Analysis by Distribution Channel, 2023-2033
Figure 149: South Asia & Pacific Market Attractiveness Analysis by Country, 2023 to 2033
Figure 150: India Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 151: India Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 152: India Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 153: India Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 154: Indonesia Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 155: Indonesia Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 156: Indonesia Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 157: Indonesia Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 158: Thailand Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 159: Thailand Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 160: Thailand Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 161: Thailand Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 162: Philippines Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 163: Philippines Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 164: Philippines Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 165: Philippines Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 166: Malaysia Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 167: Malaysia Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 168: Malaysia Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 169: Malaysia Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 170: Vietnam Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 171: Vietnam Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 172: Vietnam Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 173: Vietnam Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 174: Australia & New Zealand Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 175: Australia & New Zealand Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 176: Australia & New Zealand Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 177: Australia & New Zealand Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 178: East Asia Market Share, By Drug Class, 2023 (E)
Figure 179: East Asia Market Share, By Product, 2023 (E)
Figure 180: East Asia Market Share, By Indication, 2023 (E)
Figure 181: East Asia Market Share, By Distribution Channel, 2023 (E)
Figure 182: East Asia Market Share, By Country, 2023 (E)
Figure 183: East Asia Market Value (US$ Million) Analysis 2018 to 2022
Figure 184: East Asia Market Value (US$ Million) Analysis 2023 to 2033
Figure 185: East Asia Market Attractiveness Analysis by Drug Class, 2023 to 2033
Figure 186: East Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 187: East Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 188: East Asia Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 189: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 190: Japan Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 191: Japan Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 192: Japan Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 193: Japan Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 194: China Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 195: China Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 196: China Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 197: China Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 198: South Korea Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 199: South Korea Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 200: South Korea Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 201: South Korea Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 202: Central Asia Market Share, By Drug Class, 2023 (E)
Figure 203: Central Asia Market Share, By Product, 2023 (E)
Figure 204: Central Asia Market Share, By Indication, 2023 (E)
Figure 205: Central Asia Market Share, By Distribution Channel, 2023 (E)
Figure 206: Central Asia Market Value (US$ Million) Analysis 2018 to 2022
Figure 207: Central Asia Market Value (US$ Million) Analysis 2023 to 2033
Figure 208: Central Asia Market Attractiveness Analysis by Drug Class, 2023 to 2033
Figure 209: Central Asia Market Attractiveness Analysis by Product, 2023 to 2033
Figure 210: Central Asia Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 211: Central Asia Market Attractiveness Analysis by Distribution Channel, 2023 to 2033
Figure 212: Russia & Belarus Market Share, By Drug Class, 2023 (E)
Figure 213: Russia & Belarus Market Share, By Product, 2023 (E)
Figure 214: Russia & Belarus Market Share, By Indication, 2023 (E)
Figure 215: Russia & Belarus Market Share, By Distribution Channel, 2023 (E)
Figure 216: Russia & Belarus Market Value (US$ Million) Analysis 2018 to 2022
Figure 217: Russia & Belarus Market Value (US$ Million) Analysis 2023 to 2033
Figure 218: Russia & Belarus Market Attractiveness Analysis by Drug Class, 2023 to 2033
Figure 219: Russia & Belarus Market Attractiveness Analysis by Product, 2023 to 2033
Figure 220: Russia & Belarus Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 221: Russia & Belarus Market Attractiveness Analysis by Distribution Channel, 2023-2033
Figure 222: Balkan & Baltic Countries Market Share, By Drug Class, 2023 (E)
Figure 223: Balkan & Baltic Countries Market Share, By Product, 2023 (E)
Figure 224: Balkan & Baltic Countries Market Share, By Indication, 2023 (E)
Figure 225: Balkan & Baltic Countries Market Share, By Distribution Channel, 2023 (E)
Figure 226: Balkan & Baltic Countries Market Value (US$ Million) Analysis 2018 to 2022
Figure 227: Balkan & Baltic Countries Market Value (US$ Million) Analysis 2023 to 2033
Figure 228: Balkan & Baltic Countries Market Attractiveness Analysis by Drug Class, 2023 –2033
Figure 229: Balkan & Baltic Countries Market Attractiveness Analysis by Product, 2023 – 20
Figure 230: Balkan & Baltic Countries Market Attractiveness Analysis by Indication, 2023 –2033
Figure 231: Balkan & Baltic Countries Market Attractiveness Analysis by Distribution Channel, 2023 - 2033
Figure 232: Middle East and Africa Market Share, By Drug Class, 2023 (E)
Figure 233: Middle East and Africa Market Share, By Product, 2023 (E)
Figure 234: Middle East and Africa Market Share, By Indication, 2023 (E)
Figure 235: Middle East and Africa Market Share, By Distribution Channel, 2023 (E)
Figure 236: Middle East and Africa Market Share, By Country, 2023 (E)
Figure 237: Middle East and Africa Market Value (US$ Million) Analysis 2018 to 2022
Figure 238: Middle East and Africa Market Value (US$ Million) Analysis 2023 to 2033
Figure 239: Middle East and Africa Market Attractiveness Analysis by Drug Class, 2023 to 2033
Figure 240: Middle East and Africa Market Attractiveness Analysis by Product, 2023 to 2033
Figure 241: Middle East and Africa Market Attractiveness Analysis by Indication, 2023 to 2033
Figure 242: Middle East and Africa Market Attractiveness Analysis by Distribution Channel,
Figure 243: Middle East and Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 244: GCC Countries Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 245: GCC Countries Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 246: GCC Countries Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 247: GCC Countries Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033
Figure 248: Kingdom of Saudi Arabia Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 249: Kingdom of Saudi Arabia Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 250: Kingdom of Saudi Arabia Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 251: Kingdom of Saudi Arabia Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 252: Türkiye Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 253: Türkiye Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 254: Türkiye Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 255: Türkiye Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 256: Northern Africa Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 257: Northern Africa Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 258: Northern Africa Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 259: Northern Africa Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 260: South Africa Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 261: South Africa Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 262: South Africa Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 263: South Africa Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 264: Israel Market Share Analysis (%) by Drug Class, 2022 (A) & 2033 (F)
Figure 265: Israel Market Share Analysis (%) by Product,2022 (A) & 2033 (F)
Figure 266: Israel Market Share Analysis (%) by Indication, 2022 (A) & 2033 (F)
Figure 267: Israel Market Share Analysis (%) by Distribution Chnanel,2022 (A) & 2033 (F)
Figure 268: Key Developments, By Type of Development
Figure 269: Key Developments, By Year
The United States, Japan, and China dominate the global pain therapeutic injectables market.
The pain therapeutic injectables market is forecast to register a CAGR of 4.5% through 2033.
The overall global painkillers market has a value of around USD 19.3 Billion in 2022.
Technological advancement disrupts the current market trends, such as the development of new pain medications and delivery methods.
The global market size of pain therapeutic injectables is to reach USD 30.9 Billion by 2033.
Explore Pharmaceuticals Insights
Pain Therapeutic Injectables Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
